99 related articles for article (PubMed ID: 4413508)
1. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
[No Abstract] [Full Text] [Related]
2. [Free amino acids in blood and cerebrospinal fluid in Parkinson's disease].
TORRE M; SCARZELLA R; ZANALDA A
Minerva Med; 1953 Jul; 44(59-60):256. PubMed ID: 13110848
[No Abstract] [Full Text] [Related]
3. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
Araki K; Takino T; Ida S; Kuriyama K
Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
[TBL] [Abstract][Full Text] [Related]
4. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
Mally J; Szalai G; Stone TW
J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
[TBL] [Abstract][Full Text] [Related]
5. Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries.
Lakke JP; Teelken AW; vd Voet H; Wolthers BG
Adv Neurol; 1987; 45():243-7. PubMed ID: 3825697
[No Abstract] [Full Text] [Related]
6. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
Engelborghs S; Marescau B; De Deyn PP
Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
[TBL] [Abstract][Full Text] [Related]
7. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
Lakke JP; Teelken AW
Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
[TBL] [Abstract][Full Text] [Related]
8. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid amino acids in extrapyramidal disorders before and after L-DOPA treatment.
Van Sande M; Caers J; Lowenthal A
Z Neurol; 1971 Apr; 199(1):24-9. PubMed ID: 4102746
[No Abstract] [Full Text] [Related]
10. [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].
Gründig E; Gerstenbrand F; Bruck J; Gnad H; Prosenz P; Simanyi M
Dtsch Z Nervenheilkd; 1969; 196(3):256-65. PubMed ID: 5820717
[No Abstract] [Full Text] [Related]
11. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of amino acids in the cerebrospinal fluid].
Mashiko N
Nihon Rinsho; 1973 May; 31(5):1029-37. PubMed ID: 4738411
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid neuraminic acid in parkinsonism and schizophrenia.
PAPADOPOULOS NM; McLANE JE; O'DOHERTY D; HESS WC
J Nerv Ment Dis; 1959 May; 128(5):450-2. PubMed ID: 13665366
[No Abstract] [Full Text] [Related]
14. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
Lipman IJ; Papadopoulos NM
Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
[No Abstract] [Full Text] [Related]
16. [Chromatography of free amino acids in the cerebrospinal fluid of normal old subjects].
TORRE M; SCARZELLA R; ZANALDA A
Boll Soc Ital Biol Sper; 1955; 31(1-2):64-5. PubMed ID: 13239810
[No Abstract] [Full Text] [Related]
17. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
18. [Chromatography and quantitative data on free amino acids in cerebrospinal fluid of normal subjects].
TORRE M; SCARZELLA R; ZANALDA A
Boll Soc Ital Biol Sper; 1953 Feb; 29(2):196-8. PubMed ID: 13081788
[No Abstract] [Full Text] [Related]
19. [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].
Gründig E; Gerstenbrand F; Bruck J; Gnad H; Prosenz P; Teuflmayr R
Dtsch Z Nervenheilkd; 1969; 196(3):236-65. PubMed ID: 5820716
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy.
Ishigami N; Tokuda T; Ikegawa M; Komori M; Kasai T; Kondo T; Matsuyama Y; Nirasawa T; Thiele H; Tashiro K; Nakagawa M
Mov Disord; 2012 Jun; 27(7):851-7. PubMed ID: 22674850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
